Decrease of CA 19–9 during chemotherapy with gemcitabine predicts survival time in patients with advanced pancreatic cancer
2000 · British Journal of Cancer · 192 citations
https://doi.org/10.1054/bjoc.1999.1035
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
30
Papers
578
Citations
9
h-index
9
i10-index
U. Halm is an academic researcher from Helios Park-Klinikum Leipzig. The author has contributed to research in topics: Esophageal and GI Pathology & Pancreatic and Hepatic Oncology Research & Gastric Cancer Management and Outcomes. The author has an h-index of 9, co-authored 26 publications.
Click to start Chat